Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human intestinal ischemia and reperfusion
2014-002970-36Phase 4Terminated
- Sponsor
- Maastricht University Medical Center+
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid and doxycycline in intestinal ischemia reperfusion injury (I/R) (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Inflammation and protease activity. Started Jan 2016; status: terminated.
02
Drugs
tranexamic aciddoxycycline
03
Conditions
intestinal ischemia reperfusion injury (I/R)
Beyond the preview
Go deeper on 2014-002970-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002970-36.